Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FM1TC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $356,629
Award facts
- Contract value 100% obligated
- $356,629.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $356,629.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. The contract carries an ultimate completion date of September 29, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating competitive selection among qualified bidders. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly for the Department of Defense healthcare systems. As a child contract under the SPE2DX IDC, this delivery order represents a specific transaction within the broader framework of the company's capability to fulfill diverse pharmaceutical and medical supply requirements. The company's federal contracting history demonstrates consistent success in competitively awarded contracts involving firm fixed-price arrangements across multiple therapeutic domains, supporting defense health operations and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FM1TC?
SPE2DB25FM1TC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FM1TC worth?
The government has obligated $356,629 on SPE2DB25FM1TC.
Is contract SPE2DB25FM1TC an order under another contract?
Yes. SPE2DB25FM1TC is a delivery order under SPE2DB22D2009, an indefinite delivery contract.
Was contract SPE2DB25FM1TC competed?
The extent of competition for SPE2DB25FM1TC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award